Amkay Products Stock Screener | Share Price & Fundamental Analysis
AMKAY
Medical Equipment
Screen Amkay Products share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹60.16 Cr.
P/E Ratio (TTM)
17.14
P/B Ratio
2.38
EPS (TTM)
₹3.96
Dividend Yield
-
Debt to Equity
0.24
52W High
-
52W Low
-
Operating Margin
5.00%
Profit Margin
5.56%
Revenue (TTM)
₹18.00
EBITDA
₹2.00
Net Income
₹1.00
Total Assets
₹30.00
Total Equity
₹24.00
Amkay Products Share Price History - Stock Screener Chart
Screen AMKAY historical share price movements with interactive charts. Analyze price trends and patterns.
Amkay Products Company Profile - Fundamental Screener
Screen Amkay Products company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AMKAY shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE0QSB01016
Amkay Products Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen AMKAY balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 30 | 18 | 15 | 16 | 14 |
| Current Assets | 17 | 12 | 9 | 10 | 10 |
| Fixed Assets | 4 | 3 | 2 | 4 | 2 |
| Liabilities | |||||
| Total Liabilities | 30 | 18 | 15 | 16 | 14 |
| Current Liabilities | 1 | 1 | 3 | 4 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 24 | 10 | 7 | 6 | 5 |
| Share Capital | 9 | 6 | 0 | 0 | 0 |
| Reserves & Surplus | 15 | 4 | 7 | 6 | 5 |
Screen AMKAY income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
| Revenue | 18 | 40 | 32 | 28 | 37 | 41 |
| Expenses | 15 | 34 | 28 | 25 | 34 | 36 |
| EBITDA | 2 | 5 | 5 | 3 | 3 | 5 |
| Operating Profit % | 5.00% | 11.00% | 11.00% | 11.00% | 7.00% | 11.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 0 |
| Interest | 0 | 0 | 1 | 1 | 0 | 0 |
| Profit Before Tax | 2 | 4 | 4 | 2 | 2 | 4 |
| Tax | 0 | 1 | 1 | 1 | 1 | 1 |
| Net Profit | 1 | 3 | 3 | 2 | 2 | 3 |
| EPS | 2.10 | 3.96 | 4.13 | 2.43 | 2.31 | 4.91 |
Amkay Products Cash Flow Screener - Liquidity Fundamentals
Screen AMKAY cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 0 | -1 | 0 | 0 | 0 | 0 |
| Investing Activities | -6 | 1 | 0 | -3 | 0 | 0 |
| Financing Activities | 8 | 0 | 0 | 3 | 0 | 0 |
| Net Cash Flow | 1 | 0 | 0 | -1 | 0 | 0 |
Screen AMKAY shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Feb | 2024-Mar | 2024-Apr | 2024-May | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 73.44% | 73.44% | 73.44% | 99.89% | 73.44% | 99.89% | 99.89% | 73.44% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 5.25% | 0.00% | 0.00% | 0.16% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 6.47% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.23% | 23.44% | 23.21% | 0.00% | 11.59% | 0.00% | 0.00% | 22.89% |
| Other Holding | 3.33% | 3.12% | 3.35% | 0.11% | 3.26% | 0.11% | 0.11% | 3.51% |
| Shareholder Count | 584 | 548 | 506 | 8 | 621 | 8 | 8 | 606 |
Amkay Products Dividend Screener - Share Yield Analysis
Screen AMKAY dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Amkay Products Index Membership - Market Screener Classification
Screen AMKAY by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Amkay Products Market Events Screener - Corporate Actions
Screen AMKAY market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -15.88% | ||
| Annual General Meeting | NA | -10.42% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.09% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | -2.17% |
| 2024-11-29 | 2024-11-29 | Quarterly Result Announcement | NA | 5.26% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.06% |
Amkay Products Competitors Screener - Peer Comparison
Screen AMKAY competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 18,011 | 50.52 | 1,759 | 22.62% | 339 | 45.27 |
| Laxmi Dental | 1,373 | 54.66 | 242 | 24.12% | 25 | 34.01 |
| Tarsons Products | 1,194 | 58.73 | 408 | 32.64% | 30 | 36.93 |
| Vasa Denticity | 955 | 63.77 | 173 | % | 15 | 41.01 |
| Osel Devices | 928 | 47.93 | 187 | 40.62% | 20 | 34.59 |
| Fabtech Technologies | 856 | 18.73 | 336 | 45.66% | 47 | 32.03 |
| Prevest Denpro | 582 | 31.21 | 67 | 13.15% | 18 | 51.16 |
| Aprameya Engineering | 502 | 28.83 | 136 | 107.77% | 16 | 35.25 |
| Hemant Surgical Industries | 352 | 44.96 | 112 | % | 8 | 38.77 |
| Nureca | 293 | 72.08 | 122 | 19.24% | 1 | 51.10 |
Amkay Products Company Announcements - News Screener
Screen AMKAY latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-12-12 | Reply To Clarification On Price Movement Sought By BSE Limited | View |
| 2025-12-11 | Clarification sought from Amkay Products Ltd | - |
| 2025-11-12 | Unaudited Financial Result For The Half Year Ended September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday 12Th November 2025 For Consider And Approve The Unaudited Financial Result For The Half Year Ended September 30 2025 | View |
| 2025-11-06 | Board Meeting Intimation for Consider And Approve The Unaudited Financial Result For The Half Year Ended September 30 2025 | View |
| 2025-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-27 | Closure of Trading Window | View |
| 2025-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-06 | Intimation Of Book Closure For The Purpose Of Annual General Meeting | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-06 | Notice Of 18Th Annual General Meeting To Be Held On Monday 29Th September 2025 Through Vc/Oavm. | View |
| 2025-07-02 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-05-23 | Audited Financial Result For The Financial Year 31St March 2025 | View |
| 2025-05-23 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May 2025 | View |
| 2025-05-14 | Board Meeting Intimation for Board Meeting Intimation For Considering And Adopting The Audited Financial Results For The Quarter And Financial Year Ended 31St March 2025 | View |
| 2025-04-22 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | View |
| 2025-04-22 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | View |